AMBRX, INC.
Patent Owner
Stats
- 78 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Jan 16, 2018 most recent publication
Details
- 78 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 5,129 Total Citation Count
- Oct 07, 2004 Earliest Filing
- 58 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0009,845 COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVESSep 12, 17Jan 11, 18[A61K, C07D, C07K]
2013/0323,821 Non-Natural Amino Acid Replication-Dependent Microorganisms and VaccinesAug 09, 13Dec 05, 13[C12N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9796754 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesMay 24, 12Oct 24, 17[A61K, C07D, A61P, C07K]
9644014 Modified animal erythropoietin polypeptides and their usesSep 15, 15May 09, 17[A61K, C12N, C07K]
9637441 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesMay 29, 14May 02, 17[A61K, C12P, C07D, C07C, G01N, C07K]
9586988 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAug 23, 13Mar 07, 17[A61K, C07C, C07K]
9517273 Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acidsApr 07, 15Dec 13, 16[A61K, C12P, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0152,187 Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand PolypeptidesAbandonedJun 14, 13Jun 04, 15[A61K, C07K]
2015/0080,559 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin DerivativesAbandonedMay 24, 12Mar 19, 15[A61K, C07K]
2015/0038,678 Interleukin-10 Polypeptide Conjugates and Their UsesAbandonedFeb 28, 13Feb 05, 15[A61K, C07K]
2015/0038,679 Interleukin-3 Polypeptide Conjugates and Their UsesAbandonedFeb 28, 13Feb 05, 15[C07K]
2015/0018,530 Novel Prodrug Containing Molecule Compositions and Their UsesAbandonedFeb 28, 13Jan 15, 15[A61K, C07K]
2014/0296,145 Modified Human Growth Hormone Polypeptides and Their UsesAbandonedApr 02, 14Oct 02, 14[A61K]
2014/0296,487 Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesAbandonedNov 22, 13Oct 02, 14[C07K]
8691940 Relaxin polypeptides comprising non-naturally encoded amino acidsWithdrawnAug 17, 11Apr 08, 14[A61K, C07K]
8557781 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesExpiredOct 26, 07Oct 15, 13[A61K, C07K]
8399614 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesExpiredOct 26, 07Mar 19, 13[C07C, C07K]
2012/0283,171 MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND THEIR USESAbandonedDec 21, 10Nov 08, 12[A61K, A61P, C07K]
2012/0283,172 MODIFIED PORCINE SOMATOTROPIN POLYPEPTIDES AND THEIR USESAbandonedDec 21, 10Nov 08, 12[A61K, A61P, C07K]
2012/0041,180 Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesAbandonedJul 18, 11Feb 16, 12[C07K]
2011/0207,914 Modified Human Plasma Polypeptide or Fc Scaffolds and Their UsesAbandonedFeb 25, 11Aug 25, 11[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.